Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

James Miller

Concepts (326)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms
44
2020
2560
2.520
Why?
Smoking
20
2019
1601
1.190
Why?
Bronchi
13
2018
270
1.160
Why?
Carcinoma in Situ
5
2019
43
1.070
Why?
Carcinoma, Squamous Cell
10
2018
642
0.740
Why?
Carcinogens
4
2012
127
0.720
Why?
Chemoprevention
3
2019
95
0.700
Why?
Vascular Endothelial Growth Factor Receptor-2
2
2012
85
0.700
Why?
Lung
16
2020
4134
0.580
Why?
Carcinoma, Small Cell
7
2008
171
0.480
Why?
Bronchoscopy
9
2019
226
0.470
Why?
Urethane
3
2012
43
0.460
Why?
Bronchopulmonary Dysplasia
2
2019
395
0.450
Why?
Sputum
8
2019
309
0.450
Why?
Iloprost
2
2012
45
0.440
Why?
Pulmonary Alveoli
4
2012
410
0.440
Why?
Hyperplasia
7
2011
176
0.440
Why?
Precancerous Conditions
7
2020
166
0.420
Why?
Neprilysin
3
1998
45
0.410
Why?
Quinazolines
2
2012
250
0.380
Why?
Biopsy
11
2019
1081
0.370
Why?
Biomarkers, Tumor
7
2015
1251
0.370
Why?
Piperidines
2
2012
216
0.370
Why?
Antineoplastic Agents
4
2013
2166
0.360
Why?
DNA Copy Number Variations
1
2011
176
0.340
Why?
Bombesin
5
1998
11
0.330
Why?
Genetic Markers
1
2011
343
0.330
Why?
Amidohydrolases
3
1998
32
0.320
Why?
Neurosecretory Systems
4
2004
31
0.310
Why?
Isotretinoin
1
2009
24
0.310
Why?
Ki-67 Antigen
3
2015
111
0.310
Why?
Tocopherols
1
2009
26
0.300
Why?
Vasodilator Agents
1
2011
330
0.300
Why?
Carcinoma, Non-Small-Cell Lung
7
2013
1123
0.300
Why?
ErbB Receptors
1
2012
610
0.300
Why?
Membrane Proteins
2
2008
1154
0.280
Why?
Neovascularization, Pathologic
6
2015
296
0.280
Why?
Mass Screening
3
2008
1310
0.270
Why?
Pulmonary Disease, Chronic Obstructive
4
2018
1049
0.270
Why?
Respiratory Mucosa
2
2008
330
0.250
Why?
Adenocarcinoma
6
2012
892
0.240
Why?
Hypoxia
1
2012
1164
0.220
Why?
Chromosomes, Human, Pair 3
4
2000
46
0.220
Why?
Carcinoma, Bronchogenic
2
2002
20
0.210
Why?
Chromosome Aberrations
4
2013
160
0.200
Why?
Tomography, Spiral Computed
1
2002
32
0.190
Why?
Middle Aged
28
2019
34434
0.190
Why?
Aged
25
2019
24574
0.190
Why?
Humans
53
2020
141187
0.180
Why?
Smokers
2
2019
144
0.180
Why?
Sensitivity and Specificity
10
2010
1973
0.180
Why?
Placebos
2
2019
198
0.170
Why?
Female
33
2019
75515
0.170
Why?
Double-Blind Method
2
2019
1983
0.170
Why?
Lung Diseases
5
2015
794
0.170
Why?
Small Cell Lung Carcinoma
2
2012
116
0.170
Why?
Tomography, X-Ray Computed
2
2020
2746
0.160
Why?
Neuropeptides
4
1998
76
0.150
Why?
Tumor Cells, Cultured
6
1998
959
0.150
Why?
Male
30
2019
69783
0.150
Why?
Radiographic Image Interpretation, Computer-Assisted
1
2020
118
0.150
Why?
Remission Induction
1
2019
309
0.140
Why?
In Situ Hybridization, Fluorescence
6
2010
310
0.140
Why?
Peptides
3
1996
978
0.140
Why?
Blotting, Western
4
2012
1234
0.140
Why?
Genes, p53
1
1997
68
0.140
Why?
Lung Diseases, Obstructive
1
1997
47
0.130
Why?
Immunohistochemistry
8
2015
1737
0.130
Why?
Point Mutation
1
1997
237
0.130
Why?
Antibodies, Monoclonal
3
2010
1448
0.130
Why?
Proteomics
2
2015
1134
0.120
Why?
Radiation Injuries, Experimental
1
1996
22
0.120
Why?
Bradykinin
1
1996
48
0.120
Why?
Endopeptidases
1
1996
85
0.120
Why?
Chromosomal Instability
2
2013
21
0.120
Why?
Smoking Cessation
1
2019
440
0.110
Why?
Hyperoxia
1
1996
91
0.110
Why?
Multiple Pulmonary Nodules
1
2015
21
0.110
Why?
Mice
10
2012
18048
0.110
Why?
Animals
13
2013
37657
0.110
Why?
Gene Expression
3
1998
1491
0.110
Why?
Methylcholanthrene
2
2012
22
0.110
Why?
Butylated Hydroxytoluene
2
2012
37
0.110
Why?
Mice, Transgenic
5
2009
2180
0.110
Why?
Antigens
1
1996
362
0.110
Why?
Risk Factors
5
2019
10438
0.100
Why?
Microarray Analysis
1
2013
116
0.100
Why?
Stem Cells
1
2018
602
0.100
Why?
Algorithms
3
2020
1763
0.100
Why?
Mutation
4
2000
4013
0.100
Why?
Epithelium
4
2018
316
0.100
Why?
Aged, 80 and over
8
2015
7856
0.100
Why?
Intramolecular Oxidoreductases
2
2004
70
0.100
Why?
Risk
5
2012
904
0.100
Why?
Carcinoma, Large Cell
1
2012
15
0.100
Why?
Biological Products
1
1996
237
0.100
Why?
Cytochrome P-450 Enzyme System
2
2004
159
0.100
Why?
Epithelial Cells
3
2007
1110
0.090
Why?
Receptors, Bombesin
1
2012
2
0.090
Why?
Bronchoalveolar Lavage Fluid
3
2002
650
0.090
Why?
Immunoenzyme Techniques
1
2012
209
0.090
Why?
Volatile Organic Compounds
1
2012
61
0.090
Why?
Cell Division
4
2000
798
0.090
Why?
Case-Control Studies
8
2012
3588
0.090
Why?
Sleep Apnea Syndromes
1
2012
90
0.090
Why?
Dose-Response Relationship, Drug
2
2010
2064
0.090
Why?
Chromosomes, Human, Pair 15
1
2011
53
0.090
Why?
Eosinophilic Granuloma
1
1990
3
0.080
Why?
Proto-Oncogene Proteins c-myc
1
2012
162
0.080
Why?
Veterans
1
2002
1514
0.080
Why?
Epithelial-Mesenchymal Transition
1
2012
213
0.080
Why?
Basic Helix-Loop-Helix Transcription Factors
1
2012
245
0.080
Why?
Antioxidants
2
2012
595
0.080
Why?
Plants, Toxic
1
1989
26
0.080
Why?
Proteins
1
1996
1010
0.080
Why?
Cell Line
5
2013
2885
0.080
Why?
Somatomedins
1
2009
28
0.080
Why?
Calcium
1
1996
1187
0.080
Why?
Genome-Wide Association Study
2
2013
1402
0.080
Why?
Predictive Value of Tests
4
2009
2070
0.080
Why?
Disease Progression
5
2018
2793
0.080
Why?
Cell Proliferation
2
2018
2504
0.080
Why?
Bronchial Neoplasms
1
2009
16
0.070
Why?
Intracellular Signaling Peptides and Proteins
2
2011
464
0.070
Why?
Chromosome Deletion
1
1989
118
0.070
Why?
Neoplasms, Glandular and Epithelial
1
2009
50
0.070
Why?
Adult
16
2018
39177
0.070
Why?
Respiratory System
1
1989
157
0.070
Why?
GPI-Linked Proteins
1
2008
76
0.070
Why?
Airway Obstruction
3
2009
165
0.070
Why?
Neoplasm Invasiveness
4
2015
509
0.070
Why?
Fluorescence
3
2009
161
0.070
Why?
Polymorphism, Genetic
1
2011
625
0.070
Why?
Alkaline Phosphatase
1
2008
149
0.070
Why?
Spectral Karyotyping
1
2007
5
0.070
Why?
Isoenzymes
1
2008
302
0.070
Why?
Cell Transformation, Neoplastic
1
2009
333
0.070
Why?
Molecular Targeted Therapy
1
2010
419
0.070
Why?
Molecular Sequence Data
5
1998
2929
0.070
Why?
Proto-Oncogene Proteins p21(ras)
1
2008
263
0.060
Why?
Pulmonary Surfactants
2
1999
106
0.060
Why?
Inflammation
1
2018
2890
0.060
Why?
Fibroblasts
3
1998
1020
0.060
Why?
Exons
2
1998
353
0.060
Why?
MicroRNAs
1
2012
689
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2132
0.060
Why?
Follow-Up Studies
2
2015
5200
0.060
Why?
Early Detection of Cancer
1
2010
441
0.060
Why?
Enzyme-Linked Immunosorbent Assay
3
2005
855
0.060
Why?
ROC Curve
3
2015
586
0.060
Why?
Adaptor Proteins, Signal Transducing
1
2008
429
0.060
Why?
Recombinant Proteins
3
1998
1357
0.060
Why?
Biomarkers
3
2010
4174
0.060
Why?
RNA, Messenger
3
1998
2828
0.060
Why?
Polymerase Chain Reaction
3
1998
1056
0.060
Why?
Growth Hormone-Releasing Hormone
1
2004
25
0.050
Why?
Acromegaly
1
2004
16
0.050
Why?
Protein Kinase Inhibitors
1
2010
914
0.050
Why?
Cytokines
1
2012
2098
0.050
Why?
Adrenocorticotropic Hormone
1
2004
148
0.050
Why?
Rats
4
2004
5629
0.050
Why?
Smoke
1
2004
148
0.050
Why?
Base Sequence
3
1998
2180
0.050
Why?
Solitary Pulmonary Nodule
1
2002
21
0.050
Why?
Neoplasm Recurrence, Local
1
2009
1073
0.050
Why?
Metaplasia
2
2018
58
0.050
Why?
Vascular Endothelial Growth Factor A
1
2005
550
0.050
Why?
Cross-Sectional Studies
2
2018
5636
0.050
Why?
Sex Factors
1
2007
2058
0.040
Why?
Hospitals, Veterans
1
2002
255
0.040
Why?
Pulmonary Fibrosis
2
1998
400
0.040
Why?
Radiation Dosage
1
2002
191
0.040
Why?
Reproducibility of Results
1
2008
3348
0.040
Why?
Gene Expression Regulation
1
1989
2599
0.040
Why?
Amino Acid Sequence
3
1994
2158
0.040
Why?
Cohort Studies
4
2015
5799
0.040
Why?
Gastrin-Releasing Peptide
2
1996
7
0.040
Why?
Autocrine Communication
1
1998
40
0.040
Why?
Desmoglein 3
1
2018
15
0.040
Why?
gamma Catenin
1
2018
13
0.040
Why?
Loss of Heterozygosity
2
2013
51
0.040
Why?
Light
1
2001
394
0.040
Why?
Signal Transduction
3
1998
5144
0.040
Why?
DNA Primers
2
1998
510
0.040
Why?
Bronchial Diseases
1
2018
37
0.040
Why?
Up-Regulation
2
2005
859
0.040
Why?
Paracrine Communication
1
1998
66
0.040
Why?
Feasibility Studies
1
2002
1018
0.040
Why?
Neoplasm Transplantation
1
1998
250
0.040
Why?
Vascular Cell Adhesion Molecule-1
1
1998
42
0.030
Why?
Time
1
2018
87
0.030
Why?
Telangiectasia, Hereditary Hemorrhagic
1
1998
14
0.030
Why?
Polymorphism, Single-Stranded Conformational
1
1997
25
0.030
Why?
Genes, Tumor Suppressor
1
1998
82
0.030
Why?
Cell Cycle Checkpoints
1
2018
97
0.030
Why?
Gene Expression Profiling
1
2005
1764
0.030
Why?
Alveolitis, Extrinsic Allergic
1
1998
97
0.030
Why?
Polymorphism, Restriction Fragment Length
1
1997
68
0.030
Why?
Likelihood Functions
1
1998
147
0.030
Why?
DNA, Complementary
1
1998
274
0.030
Why?
Gene Expression Regulation, Enzymologic
1
1998
274
0.030
Why?
Codon
1
1997
92
0.030
Why?
Neoplasm Staging
2
2012
1398
0.030
Why?
Introns
1
1998
254
0.030
Why?
Mice, Nude
1
1998
691
0.030
Why?
United States
2
2011
15220
0.030
Why?
Membrane Glycoproteins
1
1999
501
0.030
Why?
Immunoassay
2
1998
113
0.030
Why?
Incidence
3
2010
2794
0.030
Why?
Enzyme Activation
1
1998
811
0.030
Why?
Treatment Outcome
1
2011
11120
0.030
Why?
RNA, Neoplasm
1
1996
79
0.030
Why?
Glycopeptides
1
1996
43
0.030
Why?
Mesothelioma
1
1996
46
0.030
Why?
Image Processing, Computer-Assisted
1
2020
772
0.030
Why?
Sequence Analysis, DNA
1
1998
824
0.030
Why?
Proto-Oncogene Proteins
1
2018
623
0.030
Why?
Antigens, CD
2
1998
539
0.030
Why?
Machine Learning
1
2020
553
0.030
Why?
Cell Cycle Proteins
1
2018
624
0.030
Why?
Receptors, Peptide
1
1994
19
0.030
Why?
Databases, Factual
1
2020
1444
0.030
Why?
Myelin Sheath
1
1996
165
0.030
Why?
Rh-Hr Blood-Group System
1
1994
14
0.030
Why?
Erythrocyte Membrane
1
1994
53
0.030
Why?
Blotting, Southern
1
1993
75
0.030
Why?
Blotting, Northern
1
1993
198
0.030
Why?
Neoplasm Metastasis
1
1996
674
0.020
Why?
Prospective Studies
3
2012
7739
0.020
Why?
DNA, Neoplasm
1
1993
158
0.020
Why?
Solid Phase Microextraction
1
2012
9
0.020
Why?
Cells, Cultured
2
2007
4208
0.020
Why?
Endoscopy
1
2015
322
0.020
Why?
Dinoprostone
2
2004
191
0.020
Why?
Fluorescent Antibody Technique
1
1993
386
0.020
Why?
Breath Tests
1
2012
76
0.020
Why?
Cloning, Molecular
1
1993
533
0.020
Why?
Gas Chromatography-Mass Spectrometry
1
2012
136
0.020
Why?
Colorado
1
2002
4610
0.020
Why?
Enzyme Inhibitors
1
1996
854
0.020
Why?
Gene Expression Regulation, Neoplastic
1
2018
1431
0.020
Why?
Liver Neoplasms
1
1998
740
0.020
Why?
Iceland
1
2011
11
0.020
Why?
Tumor Suppressor p53-Binding Protein 1
1
2011
13
0.020
Why?
Spain
1
2011
46
0.020
Why?
Netherlands
1
2011
87
0.020
Why?
Respiratory Tract Diseases
1
1992
181
0.020
Why?
Cattle
1
1993
998
0.020
Why?
Administration, Oral
1
2012
803
0.020
Why?
Rats, Sprague-Dawley
1
1996
2520
0.020
Why?
Meta-Analysis as Topic
1
2011
185
0.020
Why?
Severity of Illness Index
1
2018
2892
0.020
Why?
Carrier Proteins
1
1994
740
0.020
Why?
Receptor, IGF Type 1
1
2009
64
0.020
Why?
Prognosis
2
2012
4073
0.020
Why?
Area Under Curve
1
2010
324
0.020
Why?
Flow Cytometry
1
1993
1197
0.020
Why?
International Agencies
1
2009
33
0.020
Why?
Cystic Fibrosis
1
1998
1126
0.020
Why?
Erythrocytes
1
1994
699
0.020
Why?
Mass Spectrometry
1
2010
739
0.020
Why?
Chromatography, High Pressure Liquid
1
1989
593
0.020
Why?
Genome, Human
1
2009
420
0.020
Why?
Pilot Projects
1
2012
1820
0.020
Why?
Models, Statistical
1
2010
671
0.020
Why?
Amino Acids
1
1989
497
0.010
Why?
Genotype
1
2011
1859
0.010
Why?
Disease Models, Animal
1
1996
4404
0.010
Why?
Receptors, Vascular Endothelial Growth Factor
1
2005
109
0.010
Why?
Genomics
1
2009
814
0.010
Why?
Epoprostenol
1
2004
136
0.010
Why?
Bronchiolitis
1
2004
85
0.010
Why?
Autoantibodies
1
2010
1470
0.010
Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2005
987
0.010
Why?
Fruit
1
2003
147
0.010
Why?
Vegetables
1
2003
161
0.010
Why?
Oligonucleotide Array Sequence Analysis
1
2004
761
0.010
Why?
Genetic Predisposition to Disease
1
2011
2363
0.010
Why?
Respiratory Function Tests
1
2004
567
0.010
Why?
Pituitary Neoplasms
1
2004
197
0.010
Why?
Adenoma
1
2004
220
0.010
Why?
Regression Analysis
1
2003
1020
0.010
Why?
Single-Blind Method
1
2001
288
0.010
Why?
Weight Gain
1
2004
539
0.010
Why?
Platelet Endothelial Cell Adhesion Molecule-1
1
2000
50
0.010
Why?
Carcinoma
1
2001
230
0.010
Why?
Bronchoscopes
1
1998
3
0.010
Why?
RNA
1
2005
930
0.010
Why?
Endoglin
1
1998
18
0.010
Why?
Random Allocation
1
1998
367
0.010
Why?
Genetic Linkage
1
1998
288
0.010
Why?
Reference Values
1
1998
805
0.010
Why?
Retrospective Studies
1
2015
16273
0.010
Why?
Comorbidity
1
2001
1662
0.010
Why?
Linear Models
1
1998
857
0.010
Why?
Tumor Suppressor Protein p53
1
2000
528
0.010
Why?
Longitudinal Studies
1
2003
2902
0.010
Why?
Analysis of Variance
1
1998
1320
0.010
Why?
Diet
1
2003
1282
0.010
Why?
Receptors, Cell Surface
1
1998
397
0.010
Why?
Alleles
1
1998
891
0.010
Why?
Risk Assessment
1
2004
3490
0.010
Why?
Chromatography, Affinity
1
1994
86
0.010
Why?
Young Adult
1
2011
13673
0.010
Why?
Infant, Premature
1
1998
597
0.010
Why?
CD47 Antigen
1
1994
45
0.010
Why?
Genes
1
1994
229
0.010
Why?
Electrophoresis, Polyacrylamide Gel
1
1994
336
0.010
Why?
Endothelium, Vascular
1
2000
951
0.010
Why?
Moths
1
1994
52
0.010
Why?
Cytoplasm
1
1994
273
0.010
Why?
Carcinoid Tumor
1
1992
23
0.010
Why?
Chromosome Mapping
1
1994
504
0.010
Why?
Transfection
1
1994
943
0.010
Why?
Lymphocytes
1
1994
398
0.010
Why?
Adolescent
1
2011
22007
0.010
Why?
Mice, Inbred BALB C
1
1994
1274
0.010
Why?
Dyspnea
1
1992
257
0.010
Why?
Binding Sites
1
1994
1316
0.010
Why?
Fibrosis
1
1992
541
0.000
Why?
Phenotype
1
1998
3166
0.000
Why?
Aging
1
1998
1892
0.000
Why?
Infant, Newborn
1
1998
6275
0.000
Why?
Infant
1
1998
9818
0.000
Why?
Child, Preschool
1
1998
11457
0.000
Why?
Child
1
1998
22308
0.000
Why?
Miller's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)